{"id":1409,"date":"2026-02-26T14:39:32","date_gmt":"2026-02-26T13:39:32","guid":{"rendered":"https:\/\/genomikadlapolski.pl\/?page_id=1409"},"modified":"2026-07-13T13:17:12","modified_gmt":"2026-07-13T11:17:12","slug":"konsorcjanci","status":"publish","type":"page","link":"https:\/\/genomikadlapolski.pl\/en\/konsorcjanci\/","title":{"rendered":"Consortium members"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Consortium members<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The G4PL consortium consists of 12 institutions from across the country: 3 institutes of the \nPolish Academy of Sciences, 6 universities, 2 research institutes, and one representative of \nthe \u0141ukasiewicz research network.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Institute of Bioorganic Chemistry of the Polish Academy of Sciences, the largest institute \nof the Polish Academy of Sciences, conducts interdisciplinary research at the intersection of \nthree fields: chemistry, biology, and computer science. Since the institute\u2019s inception, its \nresearch has focused on nucleic acids\u2014RNA and DNA. Research focuses on aspects \nrelated to the synthesis, structure, and function of these molecules, their interactions with \nother molecules, as well as potential practical applications, such as in biotechnology and \nmedicine. The research utilizes modern technologies such as NMR, X-ray crystallography, \nhigh-resolution microscopy, next-generation sequencing, CRISPR, and single-cell analysis. \nIn the search for new drugs, high-throughput screening is conducted, and potential \ntherapeutics are tested in model systems such as cell lines, organoids, viruses, nematodes, \nor mice.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

IBCH PAS currently employs approximately 800 staff members, half of whom work at <\/span>the Pozna\u0144 Supercomputing and Networking Center (PSNC), which is affiliated with the \nInstitute<\/b>Approximately 50 of these individuals are doctoral students enrolled in the Pozna\u0144 \nDoctoral School of the Institutes of the Polish Academy of Sciences. In the most recent \nevaluation, the IBCH PAN was assessed in three disciplines, receiving the highest scientific \nratings: A+ in biological sciences, A+ in chemical sciences, and A in technical computer \nscience and telecommunications. The IBCH PAS extensive equipment and highly \nspecialized staff enable the implementation of nearly 200 projects annually. These efforts \nresult in, among other things, scientific publications, with an average of 180 produced each \nyear. To date, IBCH PAS staff and doctoral students have published over 2,700 articles in \njournals indexed in the Web of Science database.<\/span><\/p>

Affiliated with the PSNC Institute, it serves as a key hub in the Polish and European scientific \nIT infrastructure. It provides information and communication technology support to other \nresearch centers in Poland and abroad and participates in numerous research and \ndevelopment projects. PSNC has built and manages the POZMAN Metropolitan Network, \ncomprising over 300 km of its own fiber-optic cables connecting all research institutions in \nPozna\u0144 and the surrounding area. Since 2001, it has been implementing the construction of \nthe PIONIER research network, which comprises 6,878 km of fiber-optic cables in Poland \nand 4,080 km in Europe, connecting Polish academic communities in 21 cities and 5 \nHigh-Performance Computing Centers (KDM). It currently offers the academic community \naccess to computing resources with a total capacity of 29.6 PFLOPS and data storage \ncapabilities of 48 PB. The PSNC houses a KDM center and one of six European quantum \ncomputers. AI Factories funded by the European Commission and the Polish government \nare also currently being built there.\u00a0<\/span><\/p>

Genomics is one of the key areas of development at the IBCH PAS<\/b>, where genome analysis \ntechnologies were implemented relatively early on, first using microarrays (2004\/2005) and \nthen next-generation sequencing (2010\/2011). At that time, in collaboration with the Institute \nof Computer Science at Pozna\u0144 University of Technology, the Institute established the \nEuropean Center for Bioinformatics and Genomics (ECBiG), which carried out the first \nlarge-scale genomic project in Poland between 2016 and 2023. As part of the project, \napproximately 6,000 DNA samples were collected from residents of Poland. This resulted in \nthe creation of a reference database named <\/span>the Genomic Map of Poland<\/b>In the next project, ECBiG-MOSAIC<\/span>https:\/\/mosaic.ichb.pl\/<\/span><\/a>, in cooperation with the Stefan Cardinal Wyszy\u0144ski \nNational Institute of Cardiology \u2013 State Research Institute in Warsaw (NIKARD) and the \nMaria Sk\u0142odowska-Curie National Institute of Oncology \u2013 State Research Institute \u2013 Gliwice \nUnit (NIO-PIB), approximately 4,000 DNA samples from cardiology and oncology patients \nwere collected and sequenced. In total, approximately 10,000 complete genomes of Polish \nresidents were collected, constituting the largest genomic data resource in the country to \ndate. The data is stored on PSNC servers and serves as the starting point for the G4PL \nproject.\u00a0<\/span><\/p>

Since October 2024, IBCH PAS, as one of two Polish institutions (along with the University \nof \u0141\u00f3d\u017a), has been participating in Europe\u2019s largest genomic project, <\/span>Genome of Europe<\/b> (<\/span>GoE<\/b>, <\/span>https:\/\/genomeofeurope.eu\/<\/span><\/a>).\u00a0\u00a0<\/span><\/p>

For more information, visit the Institute\u2019s website: <\/span>portal.ichb.pl\/<\/span><\/a> and PCSS: <\/span>https:\/\/www.pcss.pl\/<\/span><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Institute of Human Genetics of the Polish Academy of Sciences (IHG PAS) is a leading \nresearch center in Poland specializing in human genetics, biotechnology, and medicine, \nemploying approximately 100 staff members. It holds a Category A scientific classification in \nthe field of medical sciences and is authorized to award doctoral and postdoctoral degrees in \nmedical sciences in the discipline of medical biology. Research conducted at IHG PAS \nfocuses on analyzing the molecular basis of human diseases, developing modern diagnostic \nmethods, and advancing innovative gene and cell therapies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Institute is equipped with modern research infrastructure, including next-generation \nsequencers, flow cytometers, systems for metabolic and electrophysiological analysis, in \nvivo imaging platforms, and high-resolution microscopes. As the only center in Central and \nEastern Europe, the IHG PAS holds certification from 10X Genomics for spatial \ntranscriptomics analysis. The Institute also has a modern animal facility enabling advanced \nin vivo preclinical research. The animal facility is equipped with a modern operating room \nadapted for small-animal microsurgery and a molecular imaging system.\u00a0<\/span><\/p>

The IGC of the Polish Academy of Sciences is a member of national and international \nresearch networks and consortia, including <\/span>ERDERA<\/b> (<\/span>European Rare Diseases Research Alliance<\/span><\/i>, <\/span>https:\/\/erdera.org\/<\/span><\/a>), selected through the European Commission\u2019s Horizon Europe \ncall for proposals for a European partnership on rare diseases for the period 2024\u20132031. \nIHG PAS is the only Polish representative in this initiative.<\/span><\/p>

The Institute collaborates with numerous entities in the healthcare sector, as well as the \nmedical and pharmaceutical industries, supporting the development of innovative \ntechnologies and the transfer of knowledge into clinical practice.<\/span><\/p>

For more information, visit the Institute\u2019s website: <\/span>https:\/\/igcz.poznan.pl\/<\/span><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The M. Nencki Institute of Experimental Biology of the Polish Academy of Sciences \n(hereinafter the Nencki Institute) is one of Poland\u2019s leading research institutions, holding the \nhighest scientific category, A+, in the field of biological sciences. The Institute\u2019s activities \nfocus on three main areas: scientific research, technology transfer, and education. The \nInstitute conducts basic research in the field of biological sciences and is authorized to \naward doctoral and postdoctoral degrees in this field. The main focus of research is on new \ntherapies and diagnostic methods for neurodegenerative diseases, neurological disorders, \ncancer, diabetes, metabolic disorders, and other lifestyle-related diseases. The Institute\u2019s \nresearch team combines the latest knowledge with technological advances to develop \ninnovative scientific strategies for solving the complex problems of modern biology and \nmedicine.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Nencki Institute\u2019s international distinction stems from its combination of basic research \nwith modern technologies and the intensive transfer of knowledge into practice. Research is \nconducted in Warsaw and at the Institute\u2019s campus<\/span> in Miko\u0142ajki, where the National Center \nfor Advanced Bioimaging Analysis is located. The Nencki Institute also fulfills its mission \nthrough collaboration with industry (including as part of the SPARK Poland initiative) and by \neducating future leaders in science, including through the Warsaw Doctoral School of Exact \nand Biomedical Sciences (Warsaw-4 -PhD) and the International Doctoral School of \nBiological Sciences and Translational Medicine (Bio4Med).<\/span><\/p>

The Institute employs over 350 staff members, including leading experts in various fields of \nbiology and biomedicine. Research is supported by extensive technical facilities and service \nlaboratories offering, among other things, preclinical studies, flow cytometry, DNA \nsequencing, and a wide range of biological imaging capabilities, from electron microscopy to \nmagnetic resonance imaging.<\/span><\/p>

The Institute is involved in ambitious research projects funded by national and international \nsources. Over the past five years, it has completed and carried out more than 270 projects \nwith a total value of over 891 million PLN. The Institute collaborates with 84 centers in 23 \ncountries and participates in prestigious scientific initiatives, such as the Dioscuri programs, \nthe International Research Agenda (MAB), the Virtual Research Institute (WIB), the Human \nFrontier Science Program Organization, and SPARK Global.<\/span><\/p>

For more information, visit the Institute\u2019s website:<\/span> https:\/\/nencki.edu.pl\/pl\/<\/span><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Pozna\u0144 University of Technology (PUT) is a public technical university and one of Poland\u2019s \nleading academic institutions. The university comprises nine faculties, including the Faculty \nof Computer Science and Telecommunications, which houses the Institute of Computer \nScience, directly involved in the implementation of the G4PL project. The Institute of \nComputer Science specializes in research and education in the fields of computer science, \nalgorithms, artificial intelligence, databases, software engineering, and computer system \nsecurity. It offers degree programs in Computer Science, Artificial Intelligence, and \nBioinformatics.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

PUT represents a broad spectrum of academic disciplines and holds the highest A+ rating in \nmaterials engineering and chemical sciences, as well as an A rating in seven other \ndisciplines, including technical computer science and telecommunications. Research \nconducted at PUT is characterized by a high level of interdisciplinarity and strong ties to \nindustry. The university actively participates in international initiatives, such as the European \nUniversity Initiative (EUNICE) under the Horizon 2020 and Horizon Europe programs. An \nimportant element of the strategy is the development of dual-degree programs, the \nestablishment of an interdisciplinary Doctoral School, and the promotion of faculty and \nstudent mobility.<\/span><\/p>

Currently, 2,238 employees work at the University of Technology. The university is \nauthorized to award doctoral and postdoctoral degrees in many disciplines, including \narchitecture and urban planning, technical computer science and telecommunications, \nautomation and electronics, environmental engineering, mechanical engineering, materials \nengineering, chemical engineering, and management sciences.<\/span><\/p>

Between 2020 and 2024, PUT staff published over 5,000 papers indexed in the Web of \nScience database and carried out over 90 research projects totaling more than 100 million \nPLN. Funding came from domestic and international sources, such as the National Science \nCentre (NCN), the National Centre for Research and Development (NCBR), the Operational \nProgramme \u201cInnovation and Competitiveness\u201d (POIR), Horizon Europe, and other EU \nprograms.<\/span><\/p>

PUT is a member of multiple national and international consortia and research networks. In \nthe areas of technology transfer and the commercialization of research results, it has \nsecured 298 patents, demonstrating its high innovative potential and effective collaboration \nwith industry. The university actively develops mechanisms for intellectual property \nprotection and supports the implementation of innovative technological solutions.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The University of Warsaw (UW) is the largest and one of the leading public universities in \nPoland, with full authority to confer doctoral and postdoctoral degrees, as well as the title of \nprofessor. In the G4PL project, UW is represented by the Center for New Technologies \n(CeNT), a research and teaching unit of UW employing approximately 140 full-time staff \nmembers. Between 2020 and 2025, CeNT staff authored over 1,000 scientific publications.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CeNT is currently involved in over 160 research projects funded by domestic and \ninternational sources, including the National Science Centre (NCN), the National Centre for \nResearch and Development (NCBiR), the Foundation for Polish Science (FNP), the Ministry \nof Education and Science (MEiN), the National Agency for Research and Development \n(NAWA), IDUB, PORT, Horizon Europe, and other international programs. These are often \ninterdisciplinary projects in the fields of molecular biology, structural studies of biomolecules, \nchemical compounds and materials, synthesis and development of new materials (including \nfunctional, nano-, and biomaterials), applied physics in modern technologies, and \ncomputational sciences. This research falls within scientific disciplines rated at the highest \nlevel: chemical sciences (A+), computer science (A+), physical sciences (A+), archaeology \n(A), Earth and environmental sciences (A), and biological sciences (B+).<\/span><\/p>

The University of Warsaw (UW) is one of the partners in the Center for Preclinical Research \nand Technology (CePT) located on the Ochota Campus in Warsaw, within which a \ncomprehensive biomedical research center comprising ten collaborating research centers \nhas been established. The operation of CeNT UW within CePT ensures close collaboration \non planned work regarding standards and solutions for the development of genomics in \nPoland, including with other institutions in the capital that are not part of the G4PL \nconsortium.\u00a0<\/span><\/p>

In collaboration with the Military Medical Institute \u2014 Public Institute of Research, the \nUniversity of Warsaw is developing a network of Regional Digital Medicine Centers (RCMC), \nwhich will ultimately establish a network of biobanks, scientific databases, and analytical \nresources across Poland. Members of the CeNT UW Specialized Genomics Laboratory \nbelong to the international association CTLS (Core Technologies for Life Sciences)\u2014an \norganization dedicated to building networks that bring together scientists, technical staff, and \nadministrative personnel managing shared resources. Between 2020 and 2025, the CeNT \nUW Specialized Genomics Laboratory analyzed over 35,000 samples in more than 250 \nscientific and commercial projects, resulting in, among other things, over 60 scientific \npublications.\u00a0<\/span><\/p>

In the field of technology transfer, CeNT UW stands out for its high innovative potential, as \nevidenced by numerous patent applications and collaborations with the business community, \nincluding Genomed S.A., Warsaw Genomics S.A., MEDGEN, genXone S.A., as well as \nthrough European projects, such as the EIC Accelerator (in collaboration with MultiplexDX, \nSlovakia).<\/span><\/p>

For more information, visit the university's website: <\/span>https:\/\/www.uw.edu.pl\/<\/span><\/a> and CeNT: <\/span>https:\/\/cent.uw.edu.pl\/pl\/strona-glowna\/<\/span><\/a>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Medical University of Bia\u0142ystok (UMB) is a modern public university dedicated to training \nhighly qualified medical professionals, conducting scientific research, development, and \nimplementation projects at the highest international level, and advancing clinical practice in \nline with the latest scientific advancements.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Education is offered by three faculties: the Faculty of Medicine, which includes the \nDepartment of Dentistry and the Department of English-Language Instruction; the Faculty of \nPharmacy, which includes the Department of Laboratory Medicine; and the Faculty of Health \nSciences. The university is authorized to award doctoral and postdoctoral degrees in the \nfield of medical and health sciences in the following disciplines: medical sciences, \npharmaceutical sciences, and health sciences.<\/span><\/p>

In the evaluation of research activity for the years 2017\u20132021, UMB received an A+ rating in \nthe field of pharmaceutical sciences and an A rating in the fields of medical sciences and \nhealth sciences, placing it among the top medical universities in Poland. The international \nsignificance of UMB is confirmed by its receipt of the prestigious Maria Sk\u0142odowska-Curie \nCOFUND doctoral grant (Horizon 2020) and its membership in the EUNICE 4U consortium \nas an Associate Partner.<\/span><\/p>

UMB is a leader in innovation and R&D in fields such as artificial intelligence in medicine, \ngenomics, metabolomics, and bioinformatics. Between 2020 and 2024, UMB staff published \na total of nearly 3,500 papers, 25% of which were produced in collaboration with \ninternational partners.\u00a0<\/span><\/p>

UMB actively develops cooperation with the business community by commercializing \ninnovative products and filing national and international patent applications. Its significant \nachievements include, among others, formulations and technologies that support cancer \ntreatment, as well as innovative solutions for medicine and biotechnology.<\/span><\/p>

UMB also carries out investment and educational projects funded by European and national \ngrants totaling over 538 million PLN, continuously modernizing its research and teaching \ninfrastructure and supporting staff development. The university employs 944 faculty \nmembers, including 139 full professors and 166 habilitated doctors, which represents one of \nthe highest indicators of scientific potential in the country.<\/span><\/p>

For more information, visit the university's website: <\/span>https:\/\/www.umb.edu.pl\/<\/span><\/a>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The University of \u0141\u00f3d\u017a (U\u0141) is one of Poland\u2019s leading public universities, with full authority \nto award doctoral and postdoctoral degrees. U\u0141 offers a wide range of academic disciplines, \nmany of which received high ratings in the evaluation of research activity for the years \n2017\u20132021. Among other distinctions, the university received a Category A rating in the \nbiological and physical sciences.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The university's structure includes, among others, <\/span>Center for Digital Biology and Biomedical \nSciences \u2013 Biobank \u0141\u00f3d\u017a<\/b>which represents the university in the G4PL project. Biobank \u0141\u00f3d\u017a \nis a unique institution on a national and European scale, specializing in genomic, \nmicrobiological, and environmental analyses, and equipped with a modern infrastructure for \nstoring biological material. The center also serves as the operator of the Polish Node of the \nEuropean Genome Archive (Local <\/span>EGA<\/b>). Together with the Institute of Bioorganic Chemistry \nof the Polish Academy of Sciences, it is participating in a European project <\/span>Genome of Europe<\/b> (<\/span>GoE<\/b>).\u00a0<\/span><\/p>

The University of \u0141\u00f3d\u017a employs over 3,800 staff members, including nearly 2,300 faculty \nmembers. The research and teaching staff are highly productive in terms of \npublications\u2014nearly 22,000 works were published between 2020 and 2024. The University \nconducts large-scale research projects in collaboration with numerous national and \ninternational institutions. Since 2022, it has been a member of the UNIC alliance\u2014the \nEuropean University of Post-Industrial Cities\u2014which supports the transformation of \npost-industrial cities through social inclusion, diversity, and sustainable development.<\/span><\/p>

In the area of knowledge and innovation transfer, the university is actively expanding its \ncollaboration with industry. In 2024, 51 inventions and utility models were filed with the \nPolish Patent Office, and 8 applications were filed with foreign institutions. In the same year, \nthe University of \u0141\u00f3d\u017a obtained 24 patents, which demonstrates the university\u2019s high \npotential for implementation and innovation.<\/span><\/p>

For more information, visit the university's website: <\/span>https:\/\/www.uni.lodz.pl\/<\/span><\/a> and on the \nBiobank \u0141\u00f3d\u017a website: <\/span>https:\/\/www.biobank.uni.lodz.pl\/<\/span><\/a>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Jagiellonian University (UJ) is the oldest, and also one of the largest and best public \nuniversities in Poland. The Faculty of Biochemistry, Biophysics, and Biotechnology (WBBiB) \nis participating in the G4PL project on behalf of UJ. The faculty received a scientific category \nA rating in the Ministry\u2019s most recent evaluation. In the past, it has twice been awarded the \nhighest A+ category, and from 2014 to 2018, it held the status of a National Leading \nScientific Center (KNOW). The Faculty employs approximately 250 people, including over \n180 researchers.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

WBBiB UJ specializes in basic and interdisciplinary research in the fields of biochemistry, \nbiophysics, molecular biology, and biotechnology. Examples of research topics include: \npathogen-host interaction projects, the molecular basis of cancer, the use of stem cells in \ndisease therapies, inflammation, transcription factors and gene expression, the role of \npost-translational modifications, DNA damage and repair, phototherapy, drug transport, \nbioenergetics, and molecular modeling. The Department also develops projects with \napplication potential.\u00a0\u00a0<\/span><\/p>

Faculty members at the Faculty of Biology and Biotechnology (WBBiB) at the Jagiellonian \nUniversity publish approximately 200 scientific articles each year. Currently, the Faculty is \ncarrying out over 100 projects, including national ones (NCN, MEiN, FNP, NCBiR) and \ninternational ones\u2014such as those under the Horizon 2020, Horizon Europe, and European \nResearch Council (ERC) programs. In 2022, at WBBiB In 2022, the Dioscuri Center of \nScientific Excellence was established at WBBiB, created on the initiative of the Max Planck \nSociety and funded by the Ministry of Education and Science (MEiN) <\/span>and the German \nFederal Ministry of Education and Research (BMBF).<\/span><\/p>

WBBiB is expanding its collaboration with industry. Between 2019 and 2024, several dozen \nprojects involving companies from the biotechnology and pharmaceutical sectors were \ncarried out, and over 150 research services were provided. The faculty participates in \nstrategic consortia, such as TEAM-NET. In the process of knowledge transfer and \ncommercialization, the university is supported by the CITTRU Technology Transfer Center.\u00a0<\/span><\/p>

The WBBiB is home to the Laboratory of Biological Structure Imaging and Spatial \nTranscriptomics and the Laboratory of Proteomic Analysis\u2014unique <\/span>core facilities<\/span><\/i>, which \nmake their nationally unique equipment and expertise available to research teams, startups, \nand partners in the biotechnology, pharmaceutical, and medical industries.\u00a0<\/span><\/p>

For more information, visit the university's website: <\/span>https:\/\/www.uj.edu.pl\/<\/span><\/a> and the Faculty: <\/span>https:\/\/wbbib.uj.edu.pl\/pl<\/span><\/a>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology \u2013 State Research Institute \n(NIKARD PIB), based in Warsaw, is the leading clinical center in the field of cardiology and \ncardiac surgery in Poland. It operates as a research institute with the highest, fourth-level \nreference status and plays a key role in both scientific research and postgraduate medical \neducation in cardiology. The Institute conducts scientific research in the field of medical \nsciences, which received an A+ rating in the most recent evaluation, attesting to the highest \nquality of research. NIKARD PIB has full authority to confer doctoral and postdoctoral \ndegrees.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Institute employs over 1,300 staff members. Between 2020 and 2024, a total of over \n1,800 publications were released, including nearly 1,300 scientific articles, which have been \ncited over 12,000 times (Web of Science, 2024). The Institute carries out a number of \nresearch, development, and clinical projects funded by national and EU funds. It is a \nmember of research consortia such as HLS-EU, Discharge, and ERA-CVD. It has extensive \nexperience in popularizing research results\u2014it organizes and co-organizes various scientific \nevents and cardiology symposia. In the field of technology transfer and commercialization, \nNIKARD PIB actively collaborates with industry and carries out development projects with \nimplementation potential.\u00a0<\/span><\/p>

NIKARD PIB is the initiator and operator of four nationwide medical registries: (1) the \nNational Registry of Infectious Endocarditis; (2) the National Registry of Mechanical \nCirculatory Support; (3) the National Registry of Transvascular Electrode Extractions; (4) \nNational Registry of Arrhythmia Ablation. During the pandemic, NIKARD PIB also maintained \na central registry of COVID-19 patients. For many years, it has coordinated the Multicenter \nNational Population Health Survey (WOBASZ), a program aimed at a comprehensive \nassessment of the health status of the Polish population, with a particular focus on \ncardiovascular diseases and related risk factors. The third edition of this program is currently \nunderway, implemented as part of the National Program for Cardiovascular Diseases for \n2022\u20132032 and funded by the Minister of Health.\u00a0<\/span><\/p>

For more information, visit the Institute\u2019s website: <\/span>https:\/\/www.ikard.pl\/<\/span><\/a>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Maria Sk\u0142odowska-Curie National Institute of Oncology \u2013 State Research Institute, \nGliwice Branch (NIO PIB) is a leading scientific and clinical center in the field of oncology in \nPoland, holding the status of a research institute and carrying out tasks within the healthcare \nsystem. The Institute conducts scientific research in the field of medical sciences, in which it \nhas been awarded Category A status. NIO PIB Gliwice employs nearly 1,900 staff members, \nof whom over 100 are research personnel.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The Institute\u2019s activities focus on interdisciplinary research in the fields of clinical oncology, \nradiation therapy, nuclear medicine, oncological endocrinology, molecular biology, \nbiotechnology, chemistry, bioinformatics, and cancer epidemiology. The Institute\u2019s scientific \nand research activities closely support clinical practice, drawing on highly specialized \nresearch infrastructure and personnel.<\/span><\/p>

Over the past five years, the Institute has published 877 scientific papers, achieving an \nimpressive total impact factor of over 4,000 (an average of over 800 per year). Currently, \nover 50 research projects are underway at NIO PIB, funded by, among others, the National \nScience Centre (NCN), the National Centre for Research and Development (NCBR), the \nAgency for Science, Higher Education and Innovation (ABM), the Ministry of Education and \nScience (MEiN), and the European Commission (EC). The total value of these projects \namounts to tens of millions PLN.<\/span><\/p>

The Institute is an active participant in international consortia, including STOPSTORM \n(Horizon 2020; NIO-PIB is involved in patient recruitment, treatment, and data analysis, \nincluding the assessment of procedure quality and therapeutic parameters), EUnetCCC (EU \nJoint Action \u2013 HADEA, NIO-PIB Gliwice serves as co-leader of a task aimed at developing a \nsustainable management framework for the CCC network), and HoloSurge (HADEA, a \nproject developing advanced tools for real-time 3D holographic visualization in oncological \nsurgery, integrating AI, molecular diagnostics, and intraoperative navigation). The Institute \nalso participates in European research networks such as Endo-ERN, the MD Anderson \nGlobal Academic Program, and the European Institute of Environmental Cancer (EIEC), as \nwell as in national strategic consortia: the Center for Chemistry, Biology, and Translational \nMedicine, BioTechMed Silesia, and BIOFARMA.<\/span><\/p>

In the field of technology transfer and commercialization, NIO-PIB Gliwice has extensive \nexperience, as evidenced by numerous patent applications\u2014between 2021 and 2024, the \ninstitute registered domestic and international inventions, including in the areas of molecular \ndiagnostics for thyroid cancer, oncology, and targeted therapy.\u00a0<\/span><\/p>

For more information, visit the Institute\u2019s website: <\/span>https:\/\/nio.gov.pl\/<\/span><\/a>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u0141ukasiewicz \u2013 PORT is an interdisciplinary research and development institute belonging to \nthe \u0141ukasiewicz Research Network. It specializes in translational and implementation \nresearch at the intersection of life sciences, biotechnology, medicine, and materials \nengineering. The institute currently employs 328 staff members, including 170 people \ninvolved in research and development.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Research activities are focused on areas such as neurobiology, oncology, immunotherapy, \nbiotechnology, epidemiology, bioengineering, and lifestyle-related and infectious diseases. \n\u0141ukasiewicz \u2013 PORT conducts research based on modern laboratory infrastructure (clean \nroom, biobank, materials laboratories) and actively collaborates with industry. Between 2021 \nand 2025, the institute published 147 scientific papers in top-ranked journals (top 10% \nCiteScore), and in 2025, a groundbreaking article appeared in \"Nature\" on the role of ILC2 \nimmune cells in fighting cancer.<\/span><\/p>

Over the past five years, \u0141ukasiewicz\u2013PORT teams have carried out 108 R&D, \ninfrastructure, and educational projects with a total value exceeding 980 million PLN, \nincluding the prestigious P4Health project (15 million EUR in funding from Horizon Europe + \n15 million EUR in complementary Polish funding), which aims to establish a Center of \nExcellence for Precision Phenotyping and Biological Data Banking. Other ongoing projects \ninclude biobanking, clinical data analysis using AI, cancer therapies, and the development of \nnew types of vaccines.\u00a0<\/span><\/p>

The Institute participates in international consortia, including EUCAIM (Digital Europe) and \nBBMRI-ERIC (European biobanks), and is also the initiator of the Wroc\u0142aw BioTech Hub \ninitiative, which brings together the activities of Wroc\u0142aw\u2019s scientific community, particularly in \nthe medical sciences.<\/span><\/p>

In the area of technology transfer and commercialization, \u0141ukasiewicz \u2013 PORT has secured \n70 patents (including 10 European and 4 U.S. patents), maintains active partnerships with \nindustry, and has extensive experience in establishing spin-off companies\u201414 of which have \nbeen founded to date. The institute also performs contract research funded by companies \nand provides technology and investment consulting.<\/span><\/p>

For more information, visit the \u0141ukasiewicz \u2013 PORT website:<\/span> https:\/\/port.lukasiewicz.gov.pl\/<\/span><\/a>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRead more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tHide<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Konsorcjanci Konsorcjum G4PL tworzy 12 jednostek z ca\u0142ego kraju: 3 instytuty PAN, 6 uniwersytet\u00f3w, 2 instytuty badawcze i jeden przedstawiciel sieci badawczej \u0141ukasiewicz. Instytut Chemii Bioorganicznej PAN, najwi\u0119kszy instytut Polskiej Akademii Nauk, prowadzi interdyscyplinarne badania na styku trzech nauk: chemii, biologii i informatyki. Od pocz\u0105tku istnienia jednostki w centrum jej zainteresowa\u0144 znajduj\u0105 si\u0119 kwasy nukleinowe […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_jet_sm_ready_style":"","_jet_sm_style":"","_jet_sm_controls_values":"","_jet_sm_fonts_collection":"","_jet_sm_fonts_links":"","footnotes":""},"class_list":["post-1409","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/genomikadlapolski.pl\/en\/wp-json\/wp\/v2\/pages\/1409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomikadlapolski.pl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/genomikadlapolski.pl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/genomikadlapolski.pl\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/genomikadlapolski.pl\/en\/wp-json\/wp\/v2\/comments?post=1409"}],"version-history":[{"count":214,"href":"https:\/\/genomikadlapolski.pl\/en\/wp-json\/wp\/v2\/pages\/1409\/revisions"}],"predecessor-version":[{"id":3567,"href":"https:\/\/genomikadlapolski.pl\/en\/wp-json\/wp\/v2\/pages\/1409\/revisions\/3567"}],"wp:attachment":[{"href":"https:\/\/genomikadlapolski.pl\/en\/wp-json\/wp\/v2\/media?parent=1409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}